Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review. - sprookjes - yvandenbroek - TriplyDB

Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review.

Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review.

http://www.wikidata.org/entity/Q34351912

about

CFTR and Anoctamin 1 (ANO1) contribute to cAMP amplified exocytosis and insulin secretion in human and murine pancreatic beta-cells Update on diagnosis and monitoring of cystic fibrosis-related diabetes mellitus (CFRD)Australian standards of care for cystic fibrosis-related diabetes Diabetes in cystic fibrosis: multicenter screening results based on current guidelines CFTR is involved in the regulation of glucagon secretion in human and rodent alpha cells.Cystic fibrosis-related bone disease: insights into a growing problem.Challenges in diagnosis and management of diabetes in the young.Monitoring clinical and microbiological evolution of a cystic fibrosis patient over 26 years: experience of a Brazilian CF Centre.Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis.FOXO1 content is reduced in cystic fibrosis and increases with IGF-I treatment.Diagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis.Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets.Cystic fibrosis-related diabetes in adults: inpatient management of 121 patients during 410 admissions.Early Alterations in Glycemic Control and Pancreatic Endocrine Function in Nondiabetic Patients With Chronic Pancreatitis Comparison of cystic fibrosis-related diabetes with type 1 diabetes based on a German/Austrian Pediatric Diabetes Registry.Genetic modifiers of cystic fibrosis-related diabetes A novel case of diabetic muscle necrosis in a patient with cystic fibrosis-related diabetes.Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study Newborn screening and renal disease: where we have been; where we are now; where we are going.Improving chronic care delivery and outcomes: the impact of the cystic fibrosis Care Center Network.Accelerating implementation of biomedical research advances: critical elements of a successful 10 year Cystic Fibrosis Foundation healthcare delivery improvement initiative.The development of diabetes among Danish cystic fibrosis patients over the last two decades.Screening of glucose metabolism derangements in pediatric cystic fibrosis patients: how, when, why.Nutrition Management of Cystic Fibrosis in the 21st Century.Insulin therapy in patients with cystic fibrosis in the pre-diabetes stage: a systematic review.Diagnosing cystic fibrosis-related diabetes: current methods and challenges.Endocrine Disorders in Cystic Fibrosis The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis.Lung transplantation in patients with cystic fibrosis: special focus to infection and comorbidities.Diabetes and primary infertility in young males: do not forget cystic fibrosis.Optic disc swelling and vision loss in a patient with cystic fibrosis and diabetes.Clinical care guidelines: too much of a good thing?CFTR: a missing link between exocrine and endocrine pancreas?Transplanting the adolescent cystic fibrosis patient: can we do it?Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities.Cystic fibrosis-related diabetes in older adolescents: parental support and self-management.Diagnosis of cystic fibrosis-related glucose abnormalities: Can we shorten the standard oral glucose tolerance test?Abnormal CFTR Affects Glucagon Production by Islet α Cells in Cystic Fibrosis and Polycystic Ovarian Syndrome.Structural abnormalities in islets from very young children with cystic fibrosis may contribute to cystic fibrosis-related diabetes.

P2860

Q24298624-8FEFF673-EA18-425D-AB2E-44CB93B2FDEA Q26830633-59010744-B76A-4DBF-A79F-8DBC9D295242 Q26861211-45035F8F-726E-4C25-969D-AF6E3B24188D Q28661248-57FAD8FF-AE26-4734-A3F3-A5ED3DDFF316 Q33671461-EDF86995-20E6-41C7-8288-0B7D56FAA92A Q33771634-62A5D922-9794-48F1-8843-CE55A200A031 Q33801559-B5B33109-7C7F-47DC-AF85-A3D35AA4EB04 Q33909370-288F65F3-0D54-4DF6-935B-08597A4D4C2A Q34427525-4BBB4866-516B-4C3F-AD6A-FB86C515F5ED Q34486726-2DA66F1C-2ADC-4E2D-B5FC-5298504CBE5D Q35077819-8B77029A-3F63-45C7-A252-FF7039746964 Q35140718-FE38FFD8-9351-4DA6-AC88-CF207F99FD21 Q36499679-01E6F196-F12A-4BFB-9D03-578DCB313C4F Q36605683-0A4233D3-D136-463C-95CB-677E5B40500A Q36664923-1E7CBB2A-AB2D-4FB4-9D63-F205A424BB41 Q36720341-0D41CA95-C180-4C19-88BF-99E61AB4B0C2 Q37193385-DB6D7907-5B77-4146-BE6C-A1644056490F Q37210666-C13DFDB6-74E2-4BB4-9D11-D9AB14DCB3C9 Q37246186-A7097737-BDA9-4DAC-85C5-FC64D0431EF8 Q37938722-C2B61F74-E905-4DFA-A91E-034BC01E7913 Q38194425-C9684AE6-952F-4C90-BE54-CECA41C4FAE2 Q38194428-8610C1DA-3263-4671-8125-41558975EFE1 Q38217187-656CFF95-059D-4007-81C1-54D162548D98 Q38416187-9E3DF1C8-8359-443A-B646-DB3900FA6A24 Q38538310-8461C158-08E9-48D4-BB0A-D80A706ADE70 Q38781600-38EEDAAA-328F-4096-BB69-2013CAD5E03A Q38857042-808339DB-B765-4B1B-95F8-40B7B060D37A Q38911660-87B69618-3CAE-46F5-8D53-8BAF21646A16 Q38980646-0FF826DD-FBAE-4A0E-B9F3-853164D1213A Q39225829-EB36F8AB-2DD2-4959-A4A7-415371B4CB4F Q39660074-823A2654-2E2F-4E25-8B40-0E6A97838B07 Q41923174-5090E90D-C3EF-4803-884B-57CFD521A713 Q42343499-37EA1107-3100-464A-8F8A-FDD5A3C3E9AC Q42426856-7C16815C-22BD-45E6-B3B8-4366E7397F84 Q44145586-88A8B540-172C-4AEC-832D-E6C3976B9F66 Q44314873-B32E81E0-638D-463D-9D64-0E6275B7742F Q44392974-C0A7846B-F1E6-49A9-B2A1-0C0D0CE10E5E Q44881953-BEB93325-A45D-4E7C-8A43-0357A5527E3E Q45253869-2C606C2C-2240-40A1-855D-5E3609D37FF3 Q47154527-B2DB635D-45A2-4475-A6BC-B2233992545A

P2860

Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review.

http://www.wikidata.org/entity/Q34351912

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Epidemiology, pathophysiology, ...... diabetes: a technical review.

@ast

Epidemiology, pathophysiology, ...... diabetes: a technical review.

@en

Epidemiology, pathophysiology, ...... diabetes: a technical review.

@nl

type

label

Epidemiology, pathophysiology, ...... diabetes: a technical review.

@ast

Epidemiology, pathophysiology, ...... diabetes: a technical review.

@en

Epidemiology, pathophysiology, ...... diabetes: a technical review.

@nl

prefLabel

Epidemiology, pathophysiology, ...... diabetes: a technical review.

@ast

Epidemiology, pathophysiology, ...... diabetes: a technical review.

@en

Epidemiology, pathophysiology, ...... diabetes: a technical review.

@nl

P1433

Q34351912-A76ACE71-EA6B-43D2-8DA4-3C8E3F02BDD4

P1476

Q34351912-164AFABB-4E4C-42BA-A871-55DA4C802A7C

P2093

Q34351912-0677FD76-07A0-426D-922B-1DB3E0E7041F

Q34351912-18EBCBBA-63BD-4C3E-9DF0-7A2142525721

Q34351912-36944B08-FB83-46FC-AFF3-45CA3C366BBB

Q34351912-50B9EF2C-CF36-43FA-B11E-DF000692BE97

Q34351912-AE56459A-416E-4700-99F5-F9D83156A9F0

Q34351912-BE13F18C-CB26-4F66-B7FA-B114993BED66

Q34351912-C77E4608-6E85-4BE5-8D24-962840830A28

Q34351912-FB835822-730D-47C4-BA09-DC484E1CDD2C

P275

Q34351912-42409672-D852-43E2-A52F-D7DFAD44475E

P2860

Q34351912-056A777E-1998-42B8-A48D-74D435A31CE8

Q34351912-0FBA934B-59EE-425F-8709-0482A68FDD6A

Q34351912-13D8C196-3EAA-41F6-BF0E-BA05C3C27D36

Q34351912-1803C8C4-3BF2-4E91-9BF5-92DCDC74912B

Q34351912-29257C99-1D32-4BC7-A565-58EC14EE770B

Q34351912-2D4A30C9-FBD8-49FE-A08D-BC0EF9086C45

Q34351912-2E016673-6166-43D4-B307-CA52DCF72779

Q34351912-2F5F3809-1668-41C6-B916-89AA59E89FC1

Q34351912-3B7615B6-BA9D-436B-8F00-D231D1FB6726

Q34351912-3BF3BC49-AC2B-40C3-AF3B-621DCC671726

P304

Q34351912-032AC86D-AF6D-4A03-839A-CB37D4F26B2C

P31

Q34351912-0D531D6B-FB16-4656-A226-AA43D662B710

Q34351912-D19B7287-5063-4CDA-8C0E-EE0841A837BF

P356

Q34351912-11005B1F-7C1C-4E3E-A36A-3240AC3721A8

P407

Q34351912-365A40E4-8E6C-43A6-BDED-79DC13238EEE

P433

Q34351912-25A9E4FE-47D5-480C-A7C8-8B5750F23E88

P478

Q34351912-F4411BF9-A3F0-4197-93AE-E6E048826A83

P5008

Q34351912-294C21CC-0DE6-453A-8E08-84A94471AA38

P577

Q34351912-5391B71B-0D72-41AC-B6E1-0F63F77D2169

P5875

Q34351912-7BBA9769-A2EA-4E55-992D-61E3D743E0F2

P698

Q34351912-50646414-1407-4BBD-A0CD-8E0C2D08A0F4

P921

Q34351912-19D29DBC-1A84-4F93-9BFC-AA0B539789E6

Q34351912-1DF0E99B-CA0F-40EB-A90F-5BC642BA5D2A

Q34351912-79213D8C-93AE-48EC-B028-49F1AE80BFB0

Q34351912-F5677116-0FB0-4176-BD44-CA93BDFDEEDF

P932

Q34351912-2B9911AD-1DB1-4CF9-8058-220E8B3E5266

P356

P1433

P1476

Epidemiology, pathophysiology, ...... diabetes: a technical review.

@en

P2093

Antoinette Moran

http://www.w3.org/2001/XMLSchema#string

Bonnie Slovis

http://www.w3.org/2001/XMLSchema#string

Bruce C Marshall

http://www.w3.org/2001/XMLSchema#string

CFRD Consensus Conference Committee

http://www.w3.org/2001/XMLSchema#string

Dorothy Becker

http://www.w3.org/2001/XMLSchema#string

M Sue Kirkman

http://www.w3.org/2001/XMLSchema#string

Peter A Gottlieb

http://www.w3.org/2001/XMLSchema#string

Samuel J Casella

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality

Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis.

Cystic fibrosis-related diabetes: the presence of microvascular diabetes complications.

A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis

Insulin sensitivity in cystic fibrosis.

Diabetes in an infant with cystic fibrosis.

Microvascular complications in cystic fibrosis-related diabetes.

Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults.

Sex disparities in effects of cystic fibrosis-related diabetes on clinical outcomes: a matched study.

Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis.

P304

2677-2683

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC10-1279

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49643482

http://www.w3.org/2001/XMLSchema#string

P698

21115770

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

cystic fibrosis

maturity-onset diabetes of the young

P932

2992212

http://www.w3.org/2001/XMLSchema#string